Clin2
NCT07246265Possibly a fitRecruiting

Morphine clearance study for sickle cell crisis in ICU

Sickle Cell DiseaseGlomerular HyperfiltrationSickle Cell NephropathyVaso-Occlusive CrisesAcute Chest Syndrome

Part of Blood & lymphatic, Genetic & congenital, Lungs & breathing clinical trials.

This study looks at how the body clears morphine in adults with sickle cell disease who are in the intensive care unit (ICU) for a pain crisis or acute chest syndrome and are receiving morphine through a patient-controlled analgesia (PCA) pump. The goal is to understand how kidney function affects morphine breakdown.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
100 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older
  • You have sickle cell disease (types SS, SC, S-beta+, or S-beta0)
  • You are currently in an intensive care unit
  • You are having a painful crisis (vaso-occlusive crisis) or acute chest syndrome
  • You are receiving morphine through a PCA pump for pain control
  • You agree to take part in the study, or a family member can consent for you if you are unable

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT03976180Recruiting
High-flow oxygen for painful sickle cell episodes

This trial tests whether giving high-flow oxygen can help treat a painful sickle cell “vaso-occlusive crisis” (VOC) and lower the risk of a serious lung complication. You may be eligible if you’re an adult with sickle cell disease experiencing an opioid-requiring pain flare and have higher risk for lung trouble.

Créteil
NCT07498309Not yet recruiting· Phase 3
Iloprost for sickle cell pain crisis treatment

This trial tests if iloprost, a medicine that helps open blood vessels, can reduce pain from a sickle cell crisis. It's for adults with sickle cell disease who need to be in the hospital for strong pain medicine.

Rouen
NCT07369024Recruiting· Phase 2
Study of low-dose ketamine for sickle cell pain crisis

This study tests whether a low-dose of ketamine (a pain medicine) can help children and young adults with sickle cell disease who are in a pain crisis. It aims to provide better pain relief while avoiding some side effects of standard painkillers.

Torrance, California
NCT06635902Recruiting· Phase 2
Citrulline for sickle cell pain crisis

This trial tests if an intravenous medication called L-citrulline can help treat pain crises in children and young adults with sickle cell disease. Participants receive either the study drug or a placebo while in the hospital for a severe pain episode.

Washington D.C., District of Columbia
NCT06755385Not yet recruiting
Ultrasound for sickle cell pain crises

This study tests if using a bedside ultrasound (a quick, painless scan) of the chest and lungs can help doctors better understand and manage pain crises in people with sickle cell disease. If you are in the hospital for a severe pain crisis, you may be able to join.

NCT06989567Not yet recruiting· Phase 3
L-citrulline for young people with sickle cell pain crisis

This trial tests an IV medication called L-citrulline for children, teens, and young adults (ages 6–21) with sickle cell disease who are having a sudden, severe pain crisis (called a vaso-occlusive crisis). The goal is to see if it helps relieve pain quickly.

Washington D.C., District of Columbia

Hear when a new Sickle Cell Disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.